GCM
MRVI icon

Graham Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Graham Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50K Buy
+17,659
New +$59.9K ﹤0.01% 1091
2024
Q3 		– Sell
-71,038
Closed -$509K – 1246
2024
Q2 		$509K Buy
+71,038
New +$613K 0.01% 587
2022
Q3 		– Sell
-25,975
Closed -$737K – 1217
2022
Q2 		$737K Sell
25,975
-25,964
-50% -$822K 0.03% 534
2022
Q1 		$1.83M Buy
51,939
+44,026
+556% +$1.48M 0.06% 148
2021
Q4 		$331K Buy
+7,913
New +$321K 0.01% 286

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graham Capital Management's MRVI Position: Q1 2026 in Review

Graham Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 17,659 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in MRVI as recently as Q2 2024.

Graham Capital Management first reported a position in MRVI in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.83M in Q1 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Graham Capital Management held 17,659 shares of Maravai LifeSciences worth $50K as of Q1 2026.
  • Maravai LifeSciences was a new Graham Capital Management position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1091 holding.
  • Graham Capital Management first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 5 quarters since.
  • Graham Capital Management's Maravai LifeSciences position peaked at $1.83M in Q1 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.